Cyclic Nucleotide-Specific Phosphodiesterases as Potential Drug Targets for Anti-Leishmania Therapy. [electronic resource]
- Antimicrobial agents and chemotherapy 10 2018
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1098-6596
10.1128/AAC.00603-18 doi
Animals Antiprotozoal Agents--therapeutic use Cyclic AMP--metabolism Leishmania major--drug effects Leishmaniasis--drug therapy Male Mice Mice, Inbred BALB C Phosphodiesterase Inhibitors--therapeutic use Phosphoric Diester Hydrolases--metabolism